Clinical Trials Browser

Phase 2 × Injections × Tumor-Agnostic × Clear all

NCT06942767 2025-04-27

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase 2 Not yet recruiting

Adenocarcinoma

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

Phase 2 Unknown

Neoplasms

NCT03348826 2020-09-16

Study of Sodium Bicarbonate in Restoring Blocked Catheters

Phase 2 Withdrawn

Neoplasms